1. Home
  2. CCEL vs GSIW Comparison

CCEL vs GSIW Comparison

Compare CCEL & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$4.12

Market Cap

35.8M

Sector

Health Care

ML Signal

N/A

GSIW

Garden Stage Limited

HOLD

Current Price

$0.15

Market Cap

33.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
GSIW
Founded
1989
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.8M
33.9M
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
CCEL
GSIW
Price
$4.12
$0.15
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.8K
462.3K
Earning Date
10-15-2025
01-01-0001
Dividend Yield
10.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,747,500.00
$5,368,221.00
Revenue This Year
$0.30
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
283.23
52 Week Low
$3.57
$0.09
52 Week High
$8.86
$1.79

Technical Indicators

Market Signals
Indicator
CCEL
GSIW
Relative Strength Index (RSI) 49.45 45.30
Support Level $4.04 $0.14
Resistance Level $4.08 $0.15
Average True Range (ATR) 0.18 0.01
MACD 0.01 -0.00
Stochastic Oscillator 62.79 47.41

Price Performance

Historical Comparison
CCEL
GSIW

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: